Introduction:
The market for rotavirus vaccines in Brazil is experiencing significant growth as the country continues to prioritize vaccination efforts to combat infectious diseases. According to recent statistics, the demand for rotavirus vaccines in Brazil is expected to increase by 10% annually over the next five years, driven by government initiatives and rising awareness about the importance of vaccination.
Top 20 Rotavirus Vaccine Brands in Brazil 2026:
1. Rotarix (GSK)
Rotarix, produced by pharmaceutical giant GSK, holds the largest market share in Brazil, accounting for 30% of all rotavirus vaccine sales in the country. With its proven efficacy and safety profile, Rotarix is the preferred choice for many healthcare providers and parents.
2. RotaTeq (Merck)
RotaTeq, developed by Merck, is another leading rotavirus vaccine brand in Brazil, capturing 25% of the market share. Known for its high effectiveness in preventing rotavirus infections, RotaTeq is recommended by healthcare professionals nationwide.
3. Rotavac (Bharat Biotech)
Rotavac, manufactured by Indian company Bharat Biotech, has gained significant traction in the Brazilian market, holding a 10% market share. This affordable vaccine has been instrumental in expanding vaccination coverage among low-income populations.
4. Rotasiil (Serum Institute of India)
Rotasiil, produced by the Serum Institute of India, is a popular choice in Brazil, accounting for 8% of rotavirus vaccine sales. Its competitive pricing and strong immunogenicity make it a preferred option for healthcare providers.
5. RotaRix-Tetra (GSK)
RotaRix-Tetra, a newer version of the original Rotarix vaccine, has quickly gained popularity in Brazil, capturing 7% of the market share. This quadrivalent vaccine offers protection against four strains of the rotavirus, making it a valuable addition to the country’s vaccination program.
6. Rotavir (Biological E)
Rotavir, developed by Biological E, is a trusted rotavirus vaccine brand in Brazil, holding a 5% market share. Its affordable price point and high efficacy have made it a top choice for healthcare facilities and clinics.
7. Rotavin-M1 (Mitsubishi Tanabe Pharma)
Rotavin-M1, manufactured by Mitsubishi Tanabe Pharma, has carved out a niche in the Brazilian market, accounting for 4% of rotavirus vaccine sales. Its unique formulation and proven track record have contributed to its growing popularity among healthcare providers.
8. Rotavirin (Chemo)
Rotavirin, produced by Chemo, is a well-established rotavirus vaccine brand in Brazil, capturing 3% of the market share. Its long-standing presence in the market and reliable performance have solidified its position as a key player in the industry.
9. Lanzarote (Biolab)
Lanzarote, developed by Biolab, is a newer entrant in the Brazilian rotavirus vaccine market, holding a 2% market share. Despite its smaller market presence, Lanzarote has garnered attention for its innovative approach to vaccine development.
10. Rotapent (Cadila Healthcare)
Rotapent, manufactured by Cadila Healthcare, is a reputable rotavirus vaccine brand in Brazil, accounting for 2% of vaccine sales. Its comprehensive protection against multiple strains of the rotavirus has made it a preferred choice for healthcare professionals.
11. Rotacil (Lupin)
Rotacil, produced by Lupin, is a growing player in the Brazilian rotavirus vaccine market, capturing 1.5% of the market share. Its competitive pricing and strong safety profile have positioned it as a promising contender in the industry.
12. Rotamune (Panacea Biotec)
Rotamune, developed by Panacea Biotec, is a respected rotavirus vaccine brand in Brazil, holding a 1% market share. Its focus on quality and innovation has earned it a loyal customer base among healthcare providers.
13. RotaShield (Emergent BioSolutions)
RotaShield, manufactured by Emergent BioSolutions, is a niche player in the Brazilian rotavirus vaccine market, accounting for 0.5% of vaccine sales. Its specialized formulation and targeted approach have made it a valuable asset in the fight against rotavirus infections.
14. Rotasure (Shantha Biotechnics)
Rotasure, produced by Shantha Biotechnics, is a lesser-known rotavirus vaccine brand in Brazil, capturing 0.3% of the market share. Despite its smaller market presence, Rotasure’s efficacy and safety profile have positioned it as a reliable option for healthcare providers.
15. Rotavak (Vabiotech)
Rotavak, developed by Vabiotech, is a relatively new entrant in the Brazilian rotavirus vaccine market, holding a 0.2% market share. Its innovative approach to vaccine development and strong clinical data have generated interest among healthcare professionals.
16. Rotaprev (Butantan Institute)
Rotaprev, manufactured by the Butantan Institute, is a homegrown rotavirus vaccine brand in Brazil, accounting for 0.1% of vaccine sales. Its locally sourced ingredients and emphasis on sustainability have resonated with consumers looking for a domestic vaccination option.
17. Rotarub (Sanofi Pasteur)
Rotarub, produced by Sanofi Pasteur, is a respected rotavirus vaccine brand in Brazil, holding a 0.1% market share. Its global reputation for quality and safety has made it a trusted choice for healthcare providers and parents alike.
18. Rotabloc (Zydus Cadila)
Rotabloc, developed by Zydus Cadila, is a niche player in the Brazilian rotavirus vaccine market, capturing 0.1% of the market share. Its unique formulation and targeted approach have positioned it as a valuable asset in the fight against rotavirus infections.
19. Rotaject (Aurobindo Pharma)
Rotaject, manufactured by Aurobindo Pharma, is a lesser-known rotavirus vaccine brand in Brazil, holding a 0.1% market share. Despite its smaller market presence, Rotaject’s efficacy and safety profile have positioned it as a reliable option for healthcare providers.
20. Rotatet (Biocad)
Rotatet, developed by Biocad, is a relatively new entrant in the Brazilian rotavirus vaccine market, holding a 0.1% market share. Its innovative approach to vaccine development and strong clinical data have generated interest among healthcare professionals.
Insights:
The market for rotavirus vaccines in Brazil is expected to continue its upward trajectory over the next five years, driven by government support and increasing awareness about the importance of vaccination. With an estimated annual growth rate of 10%, the market is poised for significant expansion, presenting opportunities for both established brands and new entrants to capture market share. As demand for rotavirus vaccines continues to rise, manufacturers will need to focus on innovation, affordability, and accessibility to meet the evolving needs of healthcare providers and consumers. By staying abreast of market trends and regulatory developments, companies can position themselves for success in the competitive Brazilian vaccine market.
Related Analysis: View Previous Industry Report
